Intervention: Mirvetuximab soravtansine plus Bevacizumab
Found 6 matching trials
Study of Mirvetuximab Soravtansine in Combination With Bevacizumab, Carboplatin, Pegylated Liposomal Doxorubicin, Pembrolizumab, or Bevacizumab + Carboplatin in Participants With Folate Receptor Alpha (FRα) Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Cancer
PHASE1
This study comprises a Dose Escalation phase followed by a Dose Expansion p...
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
PHASE2
Ovarian cancer is a lethal disease with an estimated 310,000 new cases and ...
Status
Recruiting
Location
UC San Diego Health - Moores Cancer Center /ID# 277574
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
PHASE2
Cancer is a condition where cells in a specific part of body grow and repro...
Status
Recruiting
Location
University of Alabama at Birmingham (UAB) Hospital /ID# 274793
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
PHASE3
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate th...
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
PHASE3
This is a clinical study that has three parts. It is testing a potential ne...